When AndroGel was launched it met an unmet need. After ONE YEAR on the market AndroGel had 20% MS. Compare that to your 5-10%. Testim is a me-too, the majority of physicians see it as that and your company is struggling trying to meet the needs of customers with a half-hearted effort with your tiny sales force. Don't be proud of this MS you have--it is ONLY because of samples. BTW we will start sampling soon. Word on the street is Q3 2004-enjoy your tiny bonus for one more quarter.
[/ QUOTE ]
Most of the highest-writing docs for Testim in my territory don't store samples. Don't forget that Testim is a superior gel, so that's why they're writing it. Also keep in mind that just because Androgel was 1st in class doesn't make it the BEST in class. Our sales force is smaller than yours (about 1/4 the size), but if you look at the weekly numbers, we're twice as effective PER REP, and more motivated that you folks could ever be. Testim is our first product; we have great things in store for the near and long-term.
You've out-chumped me again, Solvay.
[
Great things in store for the near and long term? Cool! Do you think you could talk to someone and make sure they leave the stink out of your exciting new products?